» Articles » PMID: 34995286

CRISPR/Cas9-mediated Bag-1 Knockout Increased Mesenchymal Characteristics of MCF-7 Cells Via Akt Hyperactivation-mediated Actin Cytoskeleton Remodeling

Overview
Journal PLoS One
Date 2022 Jan 7
PMID 34995286
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Bag-1 protein is a crucial target in cancer to increase the survival and proliferation of cells. The Bag-1 expression is significantly upregulated in primary and metastatic cancer patients compared to normal breast tissue. Overexpression of Bag-1 decreases the efficiency of conventional chemotherapeutic drugs, whereas Bag-1 silencing enhances the apoptotic efficiency of therapeutics, mostly in hormone-positive breast cancer subtypes. In this study, we generated stable Bag-1 knockout (KO) MCF-7 breast cancer cells to monitor stress-mediated cellular alterations in comparison to wild type (wt) and Bag-1 overexpressing (Bag-1 OE) MCF-7 cells. Validation and characterization studies of Bag-1 KO cells showed different cellular morphology with hyperactive Akt signaling, which caused stress-mediated actin reorganization, focal adhesion decrease and led to mesenchymal characteristics in MCF-7 cells. A potent Akt inhibitor, MK-2206, suppressed mesenchymal transition in Bag-1 KO cells. Similar results were obtained following the recovery of Bag-1 isoforms (Bag-1S, M, or L) in Bag-1 KO cells. The findings of this study emphasized that Bag-1 is a mediator of actin-mediated cytoskeleton organization through regulating Akt activation.

Citing Articles

A BAG-1-inhibitory peptide, GO-Pep, suppresses c-Raf activity in cancer.

Tatli O, Cebi E, Turk M, Dingiloglu B, Sezan A, Basturk E Commun Biol. 2025; 8(1):336.

PMID: 40021821 PMC: 11871328. DOI: 10.1038/s42003-024-07419-4.


Bag-1-mediated HSF1 phosphorylation regulates expression of heat shock proteins in breast cancer cells.

Kizilboga T, Ozden C, Can N, Onay Ucar E, Dinler Doganay G FEBS Open Bio. 2024; 14(9):1559-1569.

PMID: 39049197 PMC: 11492399. DOI: 10.1002/2211-5463.13843.


Thio-2 Inhibits Key Signaling Pathways Required for the Development and Progression of Castration-resistant Prostate Cancer.

Neeb A, Figueiredo I, Bogdan D, Cato L, Stober J, Jimenez-Vacas J Mol Cancer Ther. 2024; 23(6):791-808.

PMID: 38412481 PMC: 11148553. DOI: 10.1158/1535-7163.MCT-23-0354.


Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy.

Pan M, Solozobova V, Kuznik N, Jung N, Grassle S, Gourain V Cancer Res Commun. 2023; 3(7):1378-1396.

PMID: 37520743 PMC: 10373600. DOI: 10.1158/2767-9764.CRC-23-0111.

References
1.
Liu H, Wang Z, Bai Y, Wang M, Li Y, Wei S . Different BAG-1 isoforms have distinct functions in modulating chemotherapeutic-induced apoptosis in breast cancer cells. Acta Pharmacol Sin. 2009; 30(2):235-41. PMC: 4002464. DOI: 10.1038/aps.2008.21. View

2.
Tian X, Liu Z, Niu B, Zhang J, Tan T, Lee S . E-cadherin/β-catenin complex and the epithelial barrier. J Biomed Biotechnol. 2011; 2011:567305. PMC: 3191826. DOI: 10.1155/2011/567305. View

3.
Vandermoere F, El Yazidi-Belkoura I, Demont Y, Slomianny C, Antol J, Lemoine J . Proteomics exploration reveals that actin is a signaling target of the kinase Akt. Mol Cell Proteomics. 2006; 6(1):114-24. DOI: 10.1074/mcp.M600335-MCP200. View

4.
Townsend P, Stephanou A, Packham G, Latchman D . BAG-1: a multi-functional pro-survival molecule. Int J Biochem Cell Biol. 2004; 37(2):251-9. DOI: 10.1016/j.biocel.2004.03.016. View

5.
Ozfiliz P, Kizilboga T, Demir S, Alkurt G, Palavan-Unsal N, Arisan E . Bag-1 promotes cell survival through c-Myc-mediated ODC upregulation that is not preferred under apoptotic stimuli in MCF-7 cells. Cell Biochem Funct. 2015; 33(5):293-307. DOI: 10.1002/cbf.3114. View